Oesophageal pH monitoring using the Bravo catheter-free radio capsule

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 1, 2007, Pages 57-63

  Gillies, Richard S ^a   Stratford, Jane M ^a   Booth, Michael I ^a   Dehn, Thomas C B ^a  

^a ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

Author keywords

Bravo; Daily activities; Discomfort; Gastro oesophageal reflux disease diagnosis; pH monitoring

Indexed keywords

ADOLESCENT; ADULT; AGED; AMBULATORY MONITORING; ANTIREFLUX OPERATION; ARTICLE; BODY POSTURE; CAPSULE ENDOSCOPY; CATHETER; CONTROLLED STUDY; DAILY LIFE ACTIVITY; EATING; ESOPHAGUS; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PH; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SLEEP; STATISTICAL SIGNIFICANCE; SUPINE POSITION; TIME;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGED; ESOPHAGEAL PH MONITORING; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PAIN; TELEMETRY;

EID: 33846092108     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3280116eec     Document Type: Article

References (30)

1. Wiener GJ, Morgan TM, Copper JB, Wu WC, Castell DO, Sinclair JW, et al. Ambulatory 24-hour esophageal pH monitoring: reproducibility and variability of pH parameters. Dig Dis Sci 1988; 33:1127-1133.
2. Fass R, Hell R, Sampliner RE, Pulliam G, Graver E, Hartz V, et al. Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci 1999; 44:2263-2269.
3. Kammer P, Dahlke J, Rhoten D, Bakken T, Murray JA. Patient acceptability of prolonged pH testing. Gastroenterology 2001; 110 (Suppl 1):A427.
4. Kahrilas PJ, Quigley EMM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996; 110:1981-1996.
5. Pandolfino JE, Richter JE, Ours T, Guardino JM, Chapman J, Kahrilas PJ. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003; 98:740-749.
6. Glade MJ. Continuous ambulatory esophageal pH monitoring in the evaluation of patients with gastroesophageal reflux. JAMA 1995; 274:662-668.
7. Johnson LF, DeMeester TR. Twenty-four-hour pH monitoring of the distal esophagus: a quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974; 62:325-332.
8. Antoniazzi L, Hua HT, Streets CG, Balaji NS, Gattolin A, Theodorou D, et al. Comparison of normal values obtained with the Bravo, a catheter-free system, and conventional esophageal pH monitoring. Gastroenterology 2002; 122 (Suppl 1):A338.
9. Bruley des Varannes S, Mion F, Ducrotte P, Zerbib F, Denis P, Ponchon T, et al. Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut 2005; 54:1682-1686.
10. Bortolotti M, Gatta L, Vakil NB, Ricci C, Tampieri A, Giovannini M, et al. Simultaneous esophageal pH recording with the Bravo system and a standard probe-based device. Gastroenterology 2004; 126 (Suppl 2):A320.
11. Pandolfino JE, Zhang Q, Schreiner MA, Ghosh S, Roth MP, Kahrilas PJ. Acid reflux event detection using the Bravo wireless versus the Slimline catheter pH systems: why are the numbers so different? Gut 2005; 54:1687-1692.
12. Masclee AAM, De Best ACAM, De Graaf R, Cluysenaer OJJ, Jansen JBMJ. Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease: determination of criteria and relation to endoscopy. Scand J Gastroenterol 1990; 25:225-230.
13. Lin E, Waring JP, Ramaswamy A, Swafford V, Tucker A, Khaitan L, et al. Analysis of 245 consecutive studies using 48-hour wireless pH (Bravo) probes for GERD evaluation. DDW 2003; abstract no. 689.
14. Ward EM, Devault KR, Bouras EP, Stark ME, Wolfsen HC, Davis DM, et al. Successful oesophageal pH monitoring with a catheter-free system. Aliment Pharmacol Ther 2004; 19:449-454.
15. Streets CG, DeMeester TR, Peters JH, Bremner CG, Crookes PF, Mason RJ, et al. Clinical evaluation of the Bravo probe - a catheter-free ambulatory esophageal pH monitoring system. Gastroenterology 2001; 120 (Suppl 1):A35.
16. Dekel R, Malagon IB, Green C, Fass R. Comparison of transnasally placed wireless pH capsule (Bravo) versus traditional 24-hour esophageal pH monitoring: a randomised trial. Am J Gastroenterol 2003; 98 (Suppl 9):S38.
17. Chaudhary A, Lowe D, Guidroz A, Schade RR. Patient satisfaction with the Bravo pH probe. Am J Gastroenterol 2003; 98 (Suppl 9):S34.
18. Wong W-M, Bautista J, Dekel R, Malagnon I, Tuchinsky I, Green C, et al. Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring: a randomized trial. Aliment Pharmacol Ther 2005; 21:155-163.
19. Prakash C, Clouse R. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2005; 3:329-334.
20. Jonnalagadda S, Prakash C, Azar R, Haroian L, Clouse RE. Endoscopic removal of the Bravo pH capsule because of severe odynophagia. Am J Gastroenterol 2003; 98 (Suppl 9):S34.
21. Belafsky PC, Allen K, Castro-Del Rosario L, Roseman D. Wireless pH testing as an adjunct to unsedated transnasal esophagoscopy: the safety and efficacy of transnasal telemetry capsule placement. Otolaryngology 2004; 131:26-28.
22. Booth MI, Stratford J, Dehn TCB. Patient self-assessment of test-day symptoms in 24-h pH-metry for suspected gastroesophageal reflux disease. Scand J Gastroenterol 2001; 8:795-799.
23. Murphy DW, Yuan Y, Castell DO. Does the intraesophageal pH probe accurately detect acid reflux? Dig Dis Sci 1989; 34:649-656.
24. Johnsson F, Joelsson B. Reproducibility of ambulatory oesophageal pH monitoring. Gut 1988; 29:886-889.
25. Schlesinger PK, Donahue PE, Schmid B, Layden TJ. Limitations of 24-hour intraesophageal pH monitoring in the hospital setting. Gastroenterology 1985; 89:797-804.
26. Portale G, Choustoulakis EM, Tamhankar AP, Almogy G, Arain MA, Lord RV, et al. Evaluation of 48-hour pH monitoring with the Bravo probe, a catheter-free system, in 38 asymptomatic healthy volunteers. Gastroenterology 2003; 124 (Suppl 1):A536.
27. Lee TJ, Pandolfino JE, Goelz K, Trueworthy B, Kahrilas PJ. Esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction. Gastroenterology 2003; 124 (Suppl 1):A72.
28. Jones MP, Ebert CC, Bianchi L, Pandolfino P, Kahrilas PJ. Evaluation of duodenal and gastric acid exposure using radiotelemetry pH monitoring. Am J Gastroenterol 2003; 98 (Suppl 9):S48.
29. Schreiner MA, Kahrilas PJ, Hirano I, Lee TJ, Pandolfino JE. Bravo capsule placement in the cardia: a novel method for analysis of proximal stomach acid environment. Gastroenterology 2004; 126 (Suppl 2):A319.
30. O'Shana TL, Hynes ML, Rothstein RI. Determination of a conversion factor to permit accurate transoral placement of the Bravo pH capsule following transnasal manometry. Gastroenterology 2004; 126 (Suppl 2):A322.